How you can Improved your Organization by using this Intraoperative Neuromonitoring (IONM) Market Report
  • Published On: 25-02-2022

How you can Improved your Organization by using this Intraoperative Neuromonitoring (IONM) Market Report

Key Insights

The global Intraoperative Neuromonitoring (IONM) market was valued at USD 4.3 Billion in 2020 and is projected to reach USD 9.2 Billion by 2028, growing at a CAGR of 6.9% from 2021 to 2028.

Intraoperative neuromonitoring (IONM) protects patients by continuously monitoring the central nervous system (the brain, spinal cord, and nerves) when it is at risk during surgery. Depending on the procedure, a variety of tests can be used to measure the nervous system function.

Nerve monitoring devices are used to provide an electrical impulse to identify muscles or nerves for nerve integrity. In addition, various strategies are used by nerve stimulation which includes orthopedic trauma surgeries, neurosurgery, parotid surgeries, and head & neck surgeries. This in turn boosts the market growth of the Intraoperative Neuromonitoring (IONM) Market.

Read Full Report:

Key Findings

  • The ENT surgery segment of the Intraoperative Neuromonitoring (IONM) Market is accounted to grow at the highest CAGR of 8% in the forecasted period. The increasing number of ENT surgeries, increases awareness about diseases and increasing clinical trials across the globe are the factors to drive the market growth of the Intraoperative Neuromonitoring (IONM) Market. In addition, the availability of reimbursement facilities, monitoring procedures, and some other technological advancement are expected to drive the growth of the ENT surgery segment during the forecast period.
  • The hospital segment of the Intraoperative Neuromonitoring (IONM) Market is accounted for the highest market growth at a CAGR of 5% during the forecast period. The demand for this segment is higher due to the high growth of medical facilities, and the provision of surgical centers.
  • North America accounted for the Intraoperative Neuromonitoring (IONM) market growth at a CAGR of 7.5% in the projected period followed by Europe and APAC. The rising geriatric population, increasing use of invasive surgeries and increased neurological disorders are the major factor fueling the Intraoperative Neuromonitoring (IONM) market growth in this region.

COVID-19 Impact Analysis

The outbreak of COVID-19 in 2020 compelled governments across the world to take severe actions like border seals, lockdown, and implementing strict social distancing measures, in order to restrict swift spread of COVID-19. However, these actions had a drastic impact on the global economy, as the companies across the globe were forced to either close or partially closed their operations, leading to supply chain disruptions and impairing of various industries.

Market Segmentation

The report delivers an acute breakdown of the market based on various segments such as Products & Services, Source Type and region. This study comprises the market size in terms of revenue for each segment at the global/regional/country level along with a detailed analysis of growth prospects, challenges, and opportunities. 

Global Intraoperative Neuromonitoring (IONM) Market: Regional Analysis

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

Major players in the global Intraoperative Neuromonitoring (IONM) market are Accurate Monitoring, NeuroSentinel, Checkpoint Surgical, Bovie Medical Corporation, Sentient Medical Systems, Natus Medical, Cadwell, Bromedicon, Advanced Medical Resources, Biotronic NeuroNetwork, Medtronic, Emotiv, SpecialtyCare, NuVasive, Computational Diagnostics.

About us

Vantage Market Research is a reputed company committed to providing high quality data and market research services. The company provides quantified B2B high quality research on more than 20,000 emerging markets. The company offers detailed reports on multiple industries including chemical materials and energy, food and beverages, healthcare, technology, etc. The company comprises over 125 analysts and consultants, adding more than 1,100 market research reports to its vast database every year. The company’s clientele base spans across 70% of the Global Fortune 500 companies.

Coralia Joe
Phone : 1-20) 380-9727
Email :